Abstract: The present disclosure relates with the development of a process for producing gels from polymeric materials crosslinked with organic agents and their use controlling water in porous media under high salinity and temperature conditions. The characteristics of these gels enable them to have a good performance withstanding extreme conditions in mature Mexican oil wells and in others located in other parts of the world. The gels featured in the present disclosure include novel ionic terpolymers based on acrylamide (AM), N-vinylpyrrolidone (VP), N,N?-methylenebisacrylamide (BAA), 1-vinyl-3-butylimidazolium bromide (VIM4C[Br]) and organic crosslinking agents.

Abstract: The present invention is related to the fields of Biotechnology and Medicine. Particularly, it describes therapeutic vaccine compositions able to produce an autoimmune reaction against haemopoietic growth factors such as G-SCF and/or GM-CSF bounded to other molecules or a fragment thereof by chemical conjugation or fusion. Such vaccines compositions are useful for the treatment of inflammatory diseases, especially wherein a pathological increasing of the circulating neutrophils occurs.

Abstract: A process of freezing banana leaves that preserves their appearance, quality, and freshness without compromising their safety. The process has been developed to facilitate the freezing of the banana leaf without altering its composition and making it resistant to transportation without damaging the quality of the food. The process represents a significant step in preserving food safely and efficiently.

Abstract: Systems, methods, computing platforms, and storage media for profile matching are disclosed. Exemplary implementations may: receive a plurality of images from one or more sources; receive, via a first user device, a first request for profile matching from a first user; display, on the first user device, at least a portion of the plurality of images; receive, from the first user device, a first user input comprising one or more first preference indications for at least the portion of the plurality of images; determine an overlap between the first preference indications and one or more second preference indications received from a second user device; and in response to determining the overlap between the first and second preference indications exceeds a threshold, automatically causing the first or the second user device to indicate a match between the first and the second user.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: A container is described, which may be used as part of item sortation within a facility, as well as item deliveries to end locations. In an example, the container may be configured to transition between a collapsed state and an expanded state. The container may include a loading panel and an unloading panel. The loading panel may include a fastener such that an opening can be selectively created and closed in the expanded state. Accordingly, packaged items may be inserted and securely retained in the container through the loading panel. The unloading panel may also include a fastener such that an opening can be selectively created and closed in the expanded state. Accordingly, the packaged items may be unloaded from the container through this opening. The container may also be dimensioned to facilitate stowage of the container in the collapsed state and loading/unloading of packaged items in the expanded state.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: A container is described, which may be used as part of item sortation within a facility, as well as item deliveries to end locations. In an example, the container may be configured to transition between a collapsed state and an expanded state. The container may include a loading panel and an unloading panel. The loading panel may include a fastener such that an opening can be selectively created and closed in the expanded state. Accordingly, packaged items may be inserted and securely retained in the container through the loading panel. The unloading panel may also include a fastener such that an opening can be selectively created and closed in the expanded state. Accordingly, the packaged items may be unloaded from the container through this opening. The container may also be dimensioned to facilitate stowage of the container in the collapsed state and loading/unloading of packaged items in the expanded state.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: The method and the kit are useful as tools for classifying a patient diagnosed with mantle cell lymphoma into the category of: indolent or conventional. The method comprises: a) providing a sample from a patient suffering from mantle cell lymphoma; b) determining the level of expression of at least one gene selected from the group consisting of: RNGTT, HDGFRP3, FARP1, HMGB3, LGALS3BP, PON2, CDK2AP1, DBN1, CNR1, CNN3, SOX11, SETMAR and CSNK1E in said sample; and c) comparing the level of expression of each of the measured genes with respect to the level of expression of the same genes in a control sample; wherein the absence of expression or the underexpression of said genes with respect to the same genes in said control sample is indicative of the indolent clinical course of the MCL.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: Techniques described in this paper are associated with improving security at a facility. A system constructed in accordance with the techniques can assist security personnel with preventing incidents (e.g., crime, disorder, nuisance, property loss) at a facility, especially one open to public visitation (e.g., amusement parks, casinos, shopping centers). Assisting security personnel in preventing incidents can include readily providing adequate and appropriate security and non-security related information to security personnel, whether the security personnel (e.g., security officer) is stationed in a security office or on patrol (i.e. in the field) at the facility.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for diffuse large B cell lymphoma (DLBCL) patients.

Abstract: Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.

Abstract: A printer cartridge may define an internal cavity. The cartridge may have a body and a cover defining the internal cavity, and a light source may be disposed inside of the cartridge internal cavity. The light source may shine light through a notch formed in the body to illuminate a time card inserted into a time card time slot of a time clock. The light source may also shine light through an arrow shaped aperture to direct an employee that the appropriate time slot of the time card should be aligned under the arrow such that the printing mechanism may print the current time to the aligned time slot.